SUBSCRIBE: Print / eNewsletter
Genetic Variants Could Predict Cancer's Resistance to Radiation Therapy
This video highlights a large-scale profiling effort that seeks to identify and classify mutant alleles driving resistance to radiation therapy across different cancer types.
RT for Breast Cancer Patients Is 'Less Scary' Than Anticipated
This video examines patient fears and misconceptions regarding radiation therapy for the treatment of breast cancer.
Outcomes in Breast Cancer Patients Who Refuse Recommended Therapy
This video reviews outcomes among breast cancer patients in the United States who refused recommended therapy for their cancer.
Impact of SOFT/TEXT in Premenopausal Breast Cancer
This video reviews the impact of the SOFT/TEXT trials for the treatment of patients with premenopausal breast cancer, and ways to best use the results.
Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer
This video highlights trials studying the long-term impact of adjuvant tamoxifen and aromatase inhibitors for the treatment of patients with postmenopausal breast cancer.
Using Molecular Tools to Guide Breast Cancer Treatment
This video examines the use of molecular diagnostics for guiding adjuvant endocrine therapy in patients with breast cancer.
Tackling Endocrine Resistance in Breast Cancer
This video reviews the mechanisms of acquired and upfront endocrine resistance in estrogen receptor–positive breast cancer as well as research into strategies for overcoming this resistance.
Chemotherapy Decision-Making in Early Breast Cancer
This video discusses chemotherapy decision-making in early-stage breast cancer, and reviews tools such as PREDICT 2.0 and the MammaPrint 70-gene assay that can help guide treatment.
Planned Radiation in Axillary Management of Breast Cancer
This video examines how planned radiation will impact management of the axilla in breast cancer patients undergoing mastectomy.
Abemaciclib Shows Activity for HR-Positive Breast Cancer Brain Mets
This video examines an early trial studying abemaciclib for the treatment of brain metastases in patients with hormone receptor–positive, HER2-negative breast cancer.